search
Back to results

Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty

Primary Purpose

Osteoarthritis

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Antimicrobial Barrier Dressing
Negative Pressure Wound Therapy (NPWT)
Sponsored by
NYU Langone Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Those identified at pre-operative testing to have an elevated BMI (> 35)

Exclusion Criteria:

  • Active infection
  • previous scar or wound healing complication
  • post traumatic degenerative joint disease (DJD) with hardware
  • revision surgery
  • inflammatory arthritis
  • anticoagulation outside of the standard of care.

Sites / Locations

  • New York University School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Antimicrobial Barrier Dressing

Closed-incision Negative Pressure Therapy

Arm Description

postoperative wound dressing with either anti-microbial dressing placed in the operating room from surgery to postoperative day 7

portable NPWT device placed in the operating room from surgery to postoperative day 7

Outcomes

Primary Outcome Measures

Visual Analog Scale (VAS) Pain Score
A patient is asked to indicate his/her perceived scar severity along a 100 mm horizontal line, and this rating is then measured from the left edge (=VAS score). The total score range is 0 (worst possible scar) to 100 (best possible scar); the higher the score, the better the scarring.
Wound Evaluation Scale (WES)
WES is a 6-item scale. Items 1-5 are scored 0 (yes) or 1 (no), and item 6 is scored 0 (poor) or 1 (acceptable). The total score range is 0-6; the higher the score, the more optimal the wound healing.

Secondary Outcome Measures

Full Information

First Posted
November 14, 2017
Last Updated
March 29, 2022
Sponsor
NYU Langone Health
search

1. Study Identification

Unique Protocol Identification Number
NCT03345771
Brief Title
Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty
Official Title
Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
November 13, 2017 (Actual)
Primary Completion Date
April 1, 2021 (Actual)
Study Completion Date
June 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NYU Langone Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether an occlusive antimicrobial barrier dressing or portable negative pressure wound dressing is superior in preventing wound complications and infection rates in obese patients undergoing total joint arthroplasty (TJA). Approximately 240 subjects (120 for total knee arthroplasty and 120 for total hip arthroplasty) will be enrolled to evaluate the outcomes associated with silver impregnated dressings and negative pressure wound therapy (NPWT) in treating this subset of patients and analyze the cost benefit of each.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
230 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Antimicrobial Barrier Dressing
Arm Type
Active Comparator
Arm Description
postoperative wound dressing with either anti-microbial dressing placed in the operating room from surgery to postoperative day 7
Arm Title
Closed-incision Negative Pressure Therapy
Arm Type
Active Comparator
Arm Description
portable NPWT device placed in the operating room from surgery to postoperative day 7
Intervention Type
Combination Product
Intervention Name(s)
Antimicrobial Barrier Dressing
Other Intervention Name(s)
AQUACEL Ag Hydrofiber Dressing
Intervention Description
Ionic Silver is a soft, nonwoven pad or ribbon that features the gelling benefits of Hydrofiber technology plus antimicrobial ionic silver.
Intervention Type
Device
Intervention Name(s)
Negative Pressure Wound Therapy (NPWT)
Other Intervention Name(s)
PICO
Intervention Description
PICO provides suction known as negative Pressure wound Therapy (NPWT) which draws out excess fluid from a wound and protects the injured area from getting dirty to ultimately help promote healing. PICO consists of an nPwT pump connected to an absorbent gentle adhesive dressing
Primary Outcome Measure Information:
Title
Visual Analog Scale (VAS) Pain Score
Description
A patient is asked to indicate his/her perceived scar severity along a 100 mm horizontal line, and this rating is then measured from the left edge (=VAS score). The total score range is 0 (worst possible scar) to 100 (best possible scar); the higher the score, the better the scarring.
Time Frame
Day 8
Title
Wound Evaluation Scale (WES)
Description
WES is a 6-item scale. Items 1-5 are scored 0 (yes) or 1 (no), and item 6 is scored 0 (poor) or 1 (acceptable). The total score range is 0-6; the higher the score, the more optimal the wound healing.
Time Frame
Day 8

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Those identified at pre-operative testing to have an elevated BMI (> 35) Exclusion Criteria: Active infection previous scar or wound healing complication post traumatic degenerative joint disease (DJD) with hardware revision surgery inflammatory arthritis anticoagulation outside of the standard of care.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ran Schwarzkopf, MD
Organizational Affiliation
NYU Langone Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
New York University School of Medicine
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty

We'll reach out to this number within 24 hrs